Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
41.57
+1.60 (4.00%)
At close: May 28, 2026

SHE:301281 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
4,5023,1733,2393,686--
Market Cap Growth
39.12%-2.04%-12.13%---
Enterprise Value
4,2962,9442,7863,045--
Last Close Price
41.5729.3029.7333.44--
PE Ratio
194.87191.6853.5847.85--
PS Ratio
10.047.976.998.24--
PB Ratio
3.232.342.382.77--
P/TBV Ratio
3.522.562.592.87--
P/OCF Ratio
59.9172.99-99.54--
EV/Sales Ratio
9.587.396.016.80--
EV/EBITDA Ratio
53.6944.7631.8828.35--
EV/EBIT Ratio
133.65162.5068.7352.07--
Debt / Equity Ratio
0.110.080.03---
Debt / EBITDA Ratio
1.961.710.52---
Net Debt / Equity Ratio
-0.15-0.18-0.28-0.51-0.29-0.15
Net Debt / EBITDA Ratio
-2.59-3.75-4.43-6.39-1.22-0.60
Net Debt / FCF Ratio
3.902.641.0820.72-1.76-2.07
Asset Turnover
0.270.250.310.420.730.83
Inventory Turnover
1.521.462.252.743.433.13
Quick Ratio
2.402.784.646.861.911.00
Current Ratio
3.053.715.777.912.621.84
Return on Equity (ROE)
1.72%1.21%4.48%8.33%19.20%20.24%
Return on Assets (ROA)
1.19%0.70%1.68%3.45%9.18%10.15%
Return on Invested Capital (ROIC)
2.58%1.70%4.47%11.13%22.44%21.47%
Return on Capital Employed (ROCE)
2.10%1.20%2.80%4.30%16.30%18.40%
Earnings Yield
0.52%0.52%1.87%2.09%--
FCF Yield
-1.18%-2.95%-11.02%-0.90%--
Dividend Yield
0.13%0.17%0.67%0.90%--
Payout Ratio
110.35%149.94%53.87%40.16%--
Buyback Yield / Dilution
-2.23%-2.23%-6.49%-24.38%-0.53%0.47%
Total Shareholder Return
-2.11%-2.06%-5.82%-23.48%-0.53%0.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.